- Business Wire•23 days agoInnovus Pharma Announces the Approval to Commercialize Zestra® in South Korea Through its Partner J&H Co. LTD
Innovus Pharmaceuticals, Inc. , an emerging over-the-counter consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing and development of safe and effective non-prescription medicine and consumer care products to improve men’s and women’s health and vitality and respiratory diseases, announced today that its partner J&H Co.
- Business Wire•2 months agoInnovus Pharma Expands its Executive Management Team with the Addition of Randy Berholtz as its Executive Vice President, Corporate Development and General Counsel
Innovus Pharmaceuticals, Inc. , an emerging commercial stage pharmaceutical company that delivers safe, innovative and effective over-the-counter medicine and consumer care products to improve men’s and women’s health and respiratory diseases, today announced that Randy Berholtz will join the management team as Executive Vice President, Corporate Development and General Counsel effective January 9, ...
- Marketwired•2 months agoPowerful Marketing Platform and Strong Clinical Trials Results Boost Revenues for Innovus, Says CEO Bassam Damaj
CEOCFO Magazine, an independent investment publication that highlights important technologies and companies, today released an interview with Dr. Bassam Damaj, CEO of Innovus Pharmaceuticals, Inc. , a ...
INNV : Summary for INNOVUS PHARMA INC COM USD0.001 - Yahoo Finance
Innovus Pharmaceuticals, Inc. (INNV)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.16 - 0.16|
|52 Week Range||0.06 - 0.66|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-1.11|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|